Guide booklets and a tablet on a table

Reading information on selective intra-arterial chemoradiotherapy for tongue cancer — starting with its scope

Illustrative image

By cancer type

The designated source covers oral and tongue cancer, not all head and neck cancers. We separate what it says from what it does not.

When searching under the broad name “head and neck cancer”, information about one site is easily read as applying to all.

Scope of the source

The source covers selective intra-arterial chemoradiotherapy for oral cancer, especially advanced tongue cancer. It does not address other head and neck cancers such as pharyngeal or laryngeal cancer.

Standard treatment according to the source

The source states that surgery is the current standard for advanced tongue cancer and that this approach aims to become a future standard.

Information not in the source

  • Cost
  • Advanced Medical Care status
  • Specific side effects of chemotherapy and radiation

These should be confirmed directly with the institution.

Head and Neck Cancer Information in Japan

Source links and check date

  • 不破信和 医師 紹介サイト (口腔癌・舌癌 選択的動注併用放射線療法)
    https://fuwa-nobukazu.com/
    Checked on: 2026-10-12

FTH is not a medical institution; it is a company that provides guidance on overseas medical information, translation, and on-site interpretation support. The content of this site is for informational purposes only and does not constitute a diagnosis or treatment recommendation for any individual, nor a guarantee of treatment results. Please discuss the suitability, risks and decision to undergo any treatment with your attending medical team.

Related articles